Hepatocellular carcinoma recurrence: Predictors and management
Liver Research, ISSN: 2542-5684, Vol: 7, Issue: 4, Page: 321-332
2023
- 4Citations
- 27Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Data on Liver Cancer Detailed by Researchers at Sohag University (Hepatocellular carcinoma recurrence: Predictors and management)
2024 JAN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators publish new report on liver cancer. According to news
Review Description
Hepatocellular carcinoma (HCC), the sixth most common cancer globally, is associated with high mortality rates and more than 830,000 annual deaths. Despite advances in the available management options including surgical resection and local ablative therapies, recurrence rates after the initial treatment exceed 50%, even among patients who have undergone curative-intent therapy. Moreover, postsurgical HCC recurrence occurs in about 70% of cases five years postoperatively. The management of recurrent HCC remains undefined. This review discusses different predictors for HCC recurrence after each treatment modality and different approaches available to stratify these patients. More specific guidelines for managing HCC recurrence and strict surveillance protocols for such recurrence after initial HCC management are needed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S254256842300065X; http://dx.doi.org/10.1016/j.livres.2023.11.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85179798310&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S254256842300065X; https://dx.doi.org/10.1016/j.livres.2023.11.004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know